Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Clinical Investigation

• Publication date

  2001-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI12131PMID 11489934PMCID PMC209357
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Zebrafish genetics and vertebrate heart formation

  2001cited by this paper
• Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro

  2000cited by this paper
• Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture.

  2000cited by this paper
• Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells.

  2000cited by this paper
• Differentiation of Human Embryonic Stem Cells into Embryoid Bodies Comprising the Three Embryonic Germ Layers

  2000cited by this paper
• Intracellular Ca2+ oscillations drive spontaneous contractions in cardiomyocytes during early development.

  1999cited by this paper
• Establishment of beta-adrenergic modulation of L-type Ca2+ current in the early stages of cardiomyocyte development.

  1999cited by this paper
• Differentiation of Human Embryonic Stem Cells into Embryoid Bodies Comprising the Three Embryonic Germ Layers

  1999cited by this paper
• RNA expression of cardiac troponin T isoforms in diseased human skeletal muscle.

  1999cited by this paper
• Action potential propagation failures in long-term recordings from embryonic stem cell-derived cardiomyocytes in tissue culture

  1999cited by this paper
• Fas (CD95/Apo-1)-mediated damage to ventricular myocytes induced by cytotoxic T lymphocytes from perforin-deficient mice: a major role for inositol 1,4,5-trisphosphate.

  1998cited by this paper
• Embryonic stem cell lines derived from human blastocysts.

  1998cited by this paper
• Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation

  1998cited by this paper
• Functional Characteristics of ES Cell–derived Cardiac Precursor Cells Identified by Tissue-specific Expression of the Green Fluorescent Protein

  1998cited by this paper
• Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation

  1998cited by this paper
• Differentiation of muscle-specific proteins in chicken somites as studied by immunofluorescence microscopy

  1998cited by this paper
• Effect of inotropic interventions on contraction and Ca2+ transients in the human heart.

  1997cited by this paper
• Embryonic stem cells: a model to study structural and functional properties in cardiomyogenesis.

  1997cited by this paper
• Transplantation of fetal myocardial tissue into the infarcted myocardium of rat. A potential method for repair of infarcted myocardium?

  1996cited by this paper
• Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts.

  1996cited by this paper
• Molecular cloning and characterization of human cardiac homeobox gene CSX1.

  1996cited by this paper
• Myosin heavy chain expression in contracting myocytes isolated during embryonic stem cell cardiogenesis.

  1995cited by this paper
• Expression of transcription regulating genes in human preimplantation embryos.

  1995cited by this paper
• Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium.

  1994cited by this paper
• Cardiomyocytes differentiated in vitro from embryonic stem cells developmentally express cardiac-specific genes and ionic currents.

  1994cited by this paper
• Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, atrial and ventricular cell types.

  1993cited by this paper
• Myosin heavy chain gene expression in mouse embryoid bodies. An in vitro developmental study.

  1991cited by this paper
• Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2+ channel blockers.

  1991cited by this paper
• Transmembrane electrical characteristics of cultured human skeletal muscle cells

  1987cited by this paper
• Establishment in culture of pluripotential cells from mouse embryos

  1981cited by this paper
• Observations on the ultrastructure of developing myocardium of rat embryos

  1976cited by this paper
• Histogenesis of the embryonic myocardium.

  1970cited by this paper

• Cardiac regeneration: The present state and future direction of human pluripotent stem cell therapy.

  2026cites this paper
• Advances in Internal Organogenesis: Differentiation and Morphogenesis of Human Ventral Cavity Organs

  2026cites this paper
• MYBPC3 (c.194 C > T) mutation-mediated RyR2 dysfunction contributes to pathogenic phenotypes of DCM revealed by HiPSC modeling

  2026cites this paper
• Delayed Repolarization Caused by hERG Block With Different Drug Modalities Can Be Detected in Stem Cell‐Derived Cardiomyocytes: Incubation Time Matters

  2025cites this paper
• Advances in human induced pluripotent stem cell (hiPSC)-based disease modelling in cardiogenetics

  2025cites this paper
• Stem cell therapy used to treat Diabetes mellitus or Parkinson disease

  2025cites this paper
• Generation and purification of iPSC-derived cardiomyocytes for clinical applications

  2025cites this paper
• Integrating Hierarchical Vasculature into Engineered Cardiac Tissues

  2025cites this paper
• Petri net modeling and simulation of post-transcriptional regulatory networks of human embryonic stem cell (hESC) differentiation to cardiomyocytes

  2025cites this paper
• Understanding the Mechanisms of Chemotherapy-Related Cardiotoxicity Employing hiPSC-Derived Cardiomyocyte Models for Drug Screening and the Identification of Genetic and Epigenetic Variants

  2025cites this paper
• Pluripotent stem cell-derived cardiomyocyte transplantation: marching from bench to bedside

  2025influential citation
• Advancing organ-on-chip systems: the role of microfluidics in neuro-cardiac research

  2025cites this paper
• Stem cell therapy for patients with acute myocardial infarction: a systematic review of clinical trials

  2025cites this paper
• Recent Advances of Pluripotent Stem Cell-Derived Cardiomyocytes for Regenerative Medicine

  2025cites this paper
• Alpha-actinin-1 promotes adhesion maturation and facilitates sarcomere assembly in cardiac myocytes.

  2025cites this paper
• Human pluripotent stem cell-based cardiac repair: Lessons learned and challenges Ahead.

  2025cites this paper
• Cathepsin K inhibition promotes efficient differentiation of human embryonic stem cells to mature cardiomyocytes by mediating glucolipid metabolism and cellular energy homeostasis

  2025cites this paper
• Effect of iPS cell culture medium on the differentiation potential of induced cardiac tissues

  2025cites this paper
• FAP PET identifies earlycardiac molecular changesinduced by doxorubicin chemotherapy

  2025cites this paper
• In vitro modeling of cell types in cardiogenesis and congenital heart disease.

  2025cites this paper
• Non-Canonical Localization of Cardiac Troponins: Expanding Functions or Causing Pathologies?

  2024cites this paper
• Challenges and perspectives of heart repair with pluripotent stem cell-derived cardiomyocytes

  2024cites this paper
• Decreased intranuclear cardiac troponin I impairs cardiac autophagy through FOS/ATG5 in ageing hearts

  2024cites this paper
• Differentiating the human heart: A focus on atrioventricular canal cardiomyocytes.

  2024cites this paper
• A Novel non-invasive optical framework for simultaneous analysis of contractility and calcium in single-cell cardiomyocytes.

  2024cites this paper
• Herbal medicine: a potent booster for stem cell therapy in cardiovascular diseases

  2024cites this paper
• Differentiation of Sinoatrial-like Cardiomyocytes as a Biological Pacemaker Model

  2024cites this paper
• Modelling neurocardiac physiology and diseases using human pluripotent stem cells: current progress and future prospects

  2024cites this paper
• Signaling Pathways Governing Cardiomyocyte Differentiation

  2024cites this paper
• Molecular and cellular neurocardiology in heart disease

  2024cites this paper
• Advanced biomaterials for regenerative medicine and their possible therapeutic significance in treating COVID-19: a critical overview

  2024cites this paper
• Introduction to stem cell biology and its role in treating neurologic disorders.

  2024cites this paper
• Heart and vessels from stem cells: A short history of serendipity and good luck

  2024cites this paper
• Stem cell and exosome therapies for regenerating damaged myocardium in heart failure.

  2024cites this paper
• Using induced pluripotent stem cells for drug discovery in arrhythmias

  2024cites this paper
• Enriching Cardiomyocytes Derived from hiPSCs by Magnetic-Activated Cell Sorting (MACS).

  2024cites this paper
• Direct Cardiac Reprogramming: Current Status and Future Prospects.

  2023cites this paper
• Human Stem Cells for Cardiac Disease Modeling and Preclinical and Clinical Applications—Are We on the Road to Success?

  2023cites this paper
• Nanoimprinted Hierarchical Micro-/Nanostructured Substrates for the Growth of Cardiomyocyte Fibers

  2023cites this paper
• Recent advances in pluripotent stem cell-derived cardiac organoids and heart-on-chip applications for studying anti-cancer drug-induced cardiotoxicity

  2023cites this paper
• Multifactorial approaches to enhance maturation of human iPSC-derived cardiomyocytes

  2023cites this paper
• Maturing differentiated human pluripotent stem cells in vitro: methods and challenges.

  2023cites this paper
• Cardiac Disease Modeling with Engineered Heart Tissue.

  2023cites this paper
• Assessing Cardiac Contractility From Single Molecules to Whole Hearts

  2023cites this paper
• Cardiac regeneration: Options for repairing the injured heart

  2023cites this paper
• Building blocks of microphysiological system to model physiology and pathophysiology of human heart

  2023cites this paper
• Pancreatic transplant surgery and stem cell therapy: Finding the balance between therapeutic advances and ethical principles

  2022cites this paper
• Engineered Tissue for Cardiac Regeneration: Current Status and Future Perspectives

  2022cites this paper
• Baicalin regulates stem cells as a creative point in the treatment of climacteric syndrome

  2022cites this paper
• Modeling congenital heart disease: lessons from mice, hPSC-based models, and organoids

  2022cites this paper
• Opportunities and challenges in cardiac tissue engineering from an analysis of two decades of advances

  2022cites this paper
• Scalable manufacturing of clinical‐grade differentiated cardiomyocytes derived from human‐induced pluripotent stem cells for regenerative therapy

  2022cites this paper
• Tissue-engineered heart chambers as a platform technology for drug discovery and disease modeling.

  2022cites this paper
• Application of stem cells in engineered vascular graft and vascularized organs.

  2022cites this paper
• Application of hiPSC as a Drug Tester Via Mimicking a Personalized Mini Heart

  2022cites this paper
• Microphysiological stem cell models of the human heart

  2022cites this paper
• Cardiac Cell Therapy with Pluripotent Stem Cell-Derived Cardiomyocytes: What Has Been Done and What Remains to Do?

  2022cites this paper
• Brugada Syndrome: Different Experimental Models and the Role of Human Cardiomyocytes From Induced Pluripotent Stem Cells

  2022cites this paper
• The Structural and the Functional Aspects of Intercellular Communication in iPSC-Cardiomyocytes

  2022cites this paper
• Metabolic Determinants in Cardiomyocyte Function and Heart Regenerative Strategies

  2022cites this paper
• Morpho-functional comparison of differentiation protocols to create iPSC-derived cardiomyocytes

  2022cites this paper
• A review of protocols for human iPSC culture, cardiac differentiation, subtype-specification, maturation, and direct reprogramming

  2022cites this paper
• Differentiating Human Pluripotent Stem Cells to Cardiomyocytes Using Purified Extracellular Matrix Proteins

  2022cites this paper
• Novel Approaches to Program Cells to Differentiate into Cardiomyocytes in Myocardial Regeneration

  2022cites this paper
• Induced pluripotent stem cells for modeling of cardiac arrhythmias

  2022cites this paper
• Biomechanical Analysis of Left Ventricle Considering Myocardial Infarction and Regenerative Therapy Using Dynamic Finite Element Method

  2021cites this paper
• Methods for Isolation and Reprogramming of Various Somatic Cell Sources into iPSCs.

  2021cites this paper
• The role of metabolism in directed differentiation versus trans-differentiation of cardiomyocytes.

  2021cites this paper
• Cardiac-Speci c Gene TNNI3 as a Potential Oncogene for Kidney Cancer and Its Involvement in Wnt Signaling Pathway

  2021cites this paper
• Induced pluripotent stem cell-derived cardiomyocytes

  2021cites this paper
• Differentiation and Application of Human Pluripotent Stem Cells Derived Cardiovascular Cells for Treatment of Heart Diseases: Promises and Challenges

  2021cites this paper
• Atrial-specific hiPSC-derived cardiomyocytes in drug discovery and disease modeling.

  2021cites this paper
• Stem Cells in Cardiovascular Diseases: 30,000-Foot View

  2021cites this paper
• Pluripotent and Multipotent Stem Cells and Current Therapeutic Applications: Review

  2021cites this paper
• Engineered cardiac tissue microsphere production through direct differentiation of hydrogel-encapsulated human pluripotent stem cells.

  2021cites this paper
• Stem cell‐based therapies for cardiac diseases: The critical role of angiogenic exosomes

  2021cites this paper
• The Potential Properties of Natural Compounds in Cardiac Stem Cell Activation: Their Role in Myocardial Regeneration

  2021cites this paper
• Electrophysiological evaluation of human induced pluripotent stem cell-derived cardiomyocytes obtained by different methods.

  2021cites this paper
• Engineering Human Cardiac Muscle Patch Constructs for Prevention of Post-infarction LV Remodeling

  2021cites this paper
• Multifunctional Cardiomyocyte-Based Biosensor for Electrophysiology-Mechanical Beating-Growth Viability Monitoring

  2021cites this paper
• Application of Human Induced Pluripotent Stem Cell Technology for Cardiovascular Regenerative Pharmacology.

  2021cites this paper
• Cell Sources of Cardiomyocytes for Heart Repair

  2021cites this paper
• Transplantation of Human Pluripotent Stem Cell-Derived Cardiomyocytes for Cardiac Regenerative Therapy

  2021cites this paper
• Circular RNA hsa_circ_105039 promotes cardiomyocyte differentiation by sponging miR-17 to regulate cyclinD2 expression

  2021cites this paper
• Basic and Translational Research in Cardiac Repair and Regeneration

  2021cites this paper
• Biodegradable Synthetic Polymer Based Cardiac Patches: A Journey so far

  2021cites this paper
• An Individual Patient's “Body” on Chips—How Organismoid Theory Can Translate Into Your Personal Precision Therapy Approach

  2021cites this paper
• S-nitrosoglutathione reductase (GSNOR) deficiency accelerates cardiomyocyte differentiation of induced pluripotent stem cells.

  2021cites this paper
• Sources, Isolation and culture of stem cells?

  2021cites this paper
• Epigenetic Regulation of Cardiomyocyte Differentiation from Embryonic and Induced Pluripotent Stem Cells

  2021cites this paper
• Bioengineering approaches to treat the failing heart: from cell biology to 3D printing

  2021cites this paper
• Strategies for constructing pluripotent stem cell- and progenitor cell-derived three-dimensional cardiac micro-tissues.

  2021cites this paper
• In vitro models of the human heart.

  2021cites this paper
• E2A ablation enhances proportion of nodal-like cardiomyocytes in cardiac-specific differentiation of human embryonic stem cells

  2021cites this paper
• Specific Blood Cells Derived from Pluripotent Stem Cells: An Emerging Field with Great Potential in Clinical Cell Therapy

  2021influential citation
• Congestive Heart Failure

  2021cites this paper
• Bioengineering the Cardiac Conduction System: Advances in Cellular, Gene, and Tissue Engineering for Heart Rhythm Regeneration

  2021cites this paper
• Pten Regulates Cardiomyocyte Differentiation by Modulating Non‐CG Methylation via Dnmt3

  2021cites this paper
• Application of Patient-Specific iPSCs for Modelling and Treatment of X-Linked Cardiomyopathies

  2021cites this paper
• Intranuclear cardiac troponin I plays a functional role in regulating Atp2a2 expression in cardiomyocytes

  2021cites this paper